Avantor, Inc. IPO Advisory
Share this IPO Profile:Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
| Avantor, Inc. | AVTR - NYSE |
$18.00-$21.00 | $14.00 | $14.72 | 207 million | 5/17/2019 |
| Goldman Sachs, JP Morgan, BofA Merrill Lynch, Barclays, Jefferies | ||||||
Co-Manager(s): Credit Suisse, Deutsche Bank Securities, Evercore ISI, Guggenheim Securities, Morgan Stanley, UBS Investment Group, Citigroup, Piper Jaffray, RBC Capital, Cowen, Baird, William Blair, Janney Montgomery Scott, KeyBanc Capital Markets, Raymond James, Stephens Inc., Stifel, SunTrust Robinson Humphrey, Wells Fargo, Drexel Hamilton, PJT Partners | ||||||
| Health Care | ||||||
Filing(s): Filed 2019-02-08 Updated Prospectus 2019-03-15 Underwriters Added 2019-04-05 Underwriters Added 2019-04-05 Terms Added 2019-05-03 Terms Changed 2019-05-16 | ||||||
Avantor, Inc. Quote & Chart - Click for current quote - AVTR
IPO Boutique aggregates information on public companies and private companies, such as "AVTR" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
About Avantor, Inc. (adapted from Avantor, Inc. prospectus):
They are a leading global provider of mission critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
They are a leading global provider of mission critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "AVTR" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.